Ahead of Print: Reported Antiplatelet Use Influences Long-Term Outcome Independently in Deep Intrace

Full article access for Neurosurgery subscribers at Neurosurgery-Online.com.

BACKGROUND: Recent studies have focused on antiplatelet [AP] use in ICH patients. Several outcome predictors have been debated, but influences on mortality and outcome still remain controversial, especially for different ICH locations.

OBJECTIVE: To investigate characteristics and functional outcome of ICH patients with reported regular AP use according to hemorrhage locations.

METHODS: This retrospective analysis included 210 consecutive spontaneous ICH patients. Clinical data including the pre-admission-status, initial presentation, neuroradiological data, treatment and outcome were evaluated. Analyses were calculated for AP use versus non-AP use according to hematoma locations, and multivariate models were calculated for hematoma expansion and unfavorable (mRS=4-6) long-term functional outcome (at 1 year).

RESULTS: For all AP users ICH volume was significantly larger, 27.7ml IQR(7.4-66.1) versus 16.8ml IQR(4.2-44.7); (p=0.032). Analyses showed an increased mortality for AP users at 90 days and 1 year (p=0.036; p=0.008). Multivariately, for all ICH patients prior AP use was independently associated with hematoma expansion (OR 3.61; p=0.026) and poorer functional outcome at 1 year (OR 3.82, p=0.035). In deep ICH patients AP use was an independent predictor of an unfavorable functional outcome at 1 year (OR 4.75, p=0.048).

CONCLUSION: Hematoma expansion and more frequent unfavorable long-term functional outcome were independently associated with prior AP use for all patients, and in deep ICH patients AP use was an independent predictor of an unfavorable long-term functional outcome.

Full article access for Neurosurgery subscribers at Neurosurgery-Online.com.


Sent with MobileRSS HD FREE

Júlio Leonardo B. Pereira
Sent from my iPad


Neurosurgery from Brazil.To provide neurosurgeouns with the most timely comprehensive and relevant clinical information to improve patient care; we offer a web site where patients can view our patient-level information for free

You may also like...

Leave a Reply

%d bloggers like this: